Is Tirzepatide right for you? — 5 recommended groups and guidelines for caution when using it. Read on before you decide!

In the pursuit of healthy weight and metabolic management, we always look forward to more effective and innovative solutions. In recent years, tesipatide (such as the brand name Mounjaro®) has emerged as a shining star, sweeping through the fields of diabetes and weight loss and becoming a hot topic of discussion.

Social media is flooded with success stories of "one injection a week for easy weight loss," which is incredibly tempting. But a crucial question arises: Is tesipatide really suitable for everyone?

The answer is no. Every medication is a double-edged sword; used correctly, it's a powerful tool, but used incorrectly, it can pose risks. Today, we'll delve into the five recommended user groups and those who should use tesipatide with caution, helping you make wiser and safer decisions.

First, a simple introduction to tesipatide.

Tisipatide is a novel dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Simply put, it achieves its three core functions by "intelligently" mimicking two naturally occurring incretin hormones in the body:

1. Promotes insulin secretion : It only works when blood sugar is high, and has a low risk of hypoglycemia.

2. Inhibits glucagon secretion : Reduces glucose output from the liver.

3. Delays gastric emptying and suppresses appetite : It acts directly on the brain center, producing a strong feeling of fullness, thereby reducing calorie intake.

It is this triple mechanism that makes it exhibit superior effects in lowering blood sugar and reducing weight compared to previous drugs.

 

🌟 Five groups of people recommended to try tisipatide

If you fall into the following categories, then tesipatide may be a breakthrough option worth considering.

1. Patients with type 2 diabetes, especially those who need weight management.

This is the initial approved indication for tesiparatide. If you are struggling with poor blood sugar control, especially if you have tried traditional medications like metformin without satisfactory results, and if you are overweight, tesiparatide may be a good option for you. It not only effectively lowers glycated hemoglobin (HbA1c) but also helps with weight loss simultaneously, achieving a "two birds with one stone" effect and greatly benefiting overall metabolic health.

2. People whose BMI meets the obesity standard

For individuals with simple obesity (typically defined as BMI ≥ 30 kg/m²), tesipatide has been officially approved as a weight-loss drug. Clinical studies have shown that its weight-loss effect is very significant, with an average weight loss rate of 15%-20% or even higher, providing a new and effective alternative to surgery for severely obese patients.

3. Overweight individuals with at least one weight-related comorbidity.

If your BMI is ≥27 kg/m² (i.e., you are considered “overweight”) and you have at least one weight-related health problem, such as:

High blood pressure

High cholesterol or abnormal blood lipids

Sleep apnea syndrome

Cardiovascular diseases

You are also a suitable candidate for tesipatide. Through effective weight loss, it can indirectly improve these complications, reduce long-term health risks, and improve quality of life.

4. Those who have repeatedly failed with traditional weight loss methods and require medical intervention.

If you've tried various commercial weight loss programs, such as "eat less and exercise more," but with little or no results, or even rebound weight gain, it's likely not due to a lack of willpower, but rather a physiological mechanism at play. Tesipatide can physiologically alter your appetite regulation system, providing strong medical support for those who "gain weight even from drinking water," breaking through weight loss plateaus.

5. Those seeking long-term, convenient treatment options

Compared to traditional medications that require multiple daily doses, tesipatide only requires a subcutaneous injection once a week, making it very convenient and easy to adhere to, which can greatly improve patient medication compliance and quality of life.

⚠️ Five groups of people who should use this product with caution or should avoid using it altogether

While tesiparatide has benefits, it is not suitable for everyone. If you fall into any of the following categories, please exercise caution and consult a doctor.

1. Individuals with a personal or family history of medullary thyroid carcinoma (MTC), or those with multiple endocrine neoplasia type 2 (MEN 2).

This is a boxed warning (the most serious warning) in the tesipatide package insert . In animal studies, GLP-1 receptor agonists have been found to cause thyroid C-cell tumors in rats. While the risks in humans are not yet clear, for absolute safety reasons, it is contraindicated in individuals at risk.

2. Individuals suffering from pancreatitis

If you currently have pancreatitis or have a history of pancreatitis, extreme caution is required when using tesipatide. Although the causal relationship is not fully established, there are reported risks of pancreatitis associated with GLP-1 inhibitors. Your doctor needs to weigh the risks and benefits and monitor your condition closely.

3. Patients with severe gastrointestinal diseases

The most common side effects of tesipatide are gastrointestinal reactions, such as nausea, vomiting, diarrhea, constipation, and abdominal pain. These side effects may be amplified in patients with severe gastroparesis, inflammatory bowel disease (IBD), or other chronic gastrointestinal disorders, leading to a worsening of their condition and making them difficult to tolerate.

4. Pregnant and breastfeeding women, and those planning to have children.

Safety data for tesipatide in pregnant and breastfeeding women are currently lacking. For the absolute safety of the fetus and infant, it is generally recommended to discontinue use at least 2 months before planning pregnancy, or immediately upon discovering pregnancy. If you are in these specific periods, you should avoid use.

5. Patients with severe renal insufficiency or end-stage renal disease

For patients with mild or moderate renal impairment, no dose adjustment is usually required. However, for patients with severe renal insufficiency (eGFR <30) or those undergoing dialysis, experience with tesipatide is limited, and it should be used with caution, as dehydration caused by gastrointestinal side effects may further impair renal function.

💡 Important Note: How to begin your tesipatide journey?

After reading the above analysis, if you feel that you might be a suitable candidate, what should you do next?

1. Consult a professional doctor, rather than making your own judgment : You need a professional doctor to fully assess your health condition, medical history, and medication history to confirm whether you are suitable and to rule out contraindications.

2. Undergo a comprehensive physical examination : Before starting, your doctor may recommend that you undergo tests such as thyroid function, pancreatic enzymes, and kidney function to ensure medication safety.

3. Obtain through legitimate channels : Tesipatide is a prescription drug and must be purchased from a legitimate pharmacy or medical institution with a doctor's prescription to ensure the authenticity and safety of the drug.

4. Pay attention to your lifestyle : Medication is a powerful tool, but not a cure-all. Combining it with a healthy diet and appropriate exercise will double its effectiveness and help maintain its effects in the long term.

🏆 Asakusa Cosmetics provides you with

✔️ Authentic tesipatide (global cold chain shipping)

✔️ Hospital prescription

✔️ Online doctor consultation

✔️ Pharmacist's Medication Instructions

✔️ Comprehensive after-sales tracking service

 

⚠️ Friendly reminder: This article is for reference only. Please consult your doctor for specific medication advice.

-----------------------------------------------------------------------------------------------

Back to blog

Leave a comment

Please note, comments need to be approved before they are published.